The Global Epigenetics Diagnostic Market is the cornerstone of early intervention. These diagnostics analyze chemical modifications—such as DNA methylation and histone acetylation—to assess disease risk and therapeutic response. In 2026, the market is primarily driven by the integration of Liquid Biopsy technology, which allows for the detection of epigenetic biomarkers from a simple ... https://www.databridgemarketresearch.com/